#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	892	CRP	633	633	99.53	CRP.l15.c30.ctg.1	1295	36.5	0	.	p	.	0	K29T	NONSYN	85	87	AAG	411	413	ACG	46;45;44	A;C;G	46;45;44	.	CRP is a global regulator that represses MdtEF multidrug efflux pump expression.;CRP
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	691	2978	Escherichia_coli_EF_Tu	1185	1181	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1422	101.1	0	.	p	.	0	G394S	NONSYN	1180	1182	GGC	1176	1178	AGC	48;50;51	A,G;G;C	28,20;50;49	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	691	2978	Escherichia_coli_EF_Tu	1185	1181	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1422	101.1	1	SNP	p	L121Q	0	.	.	361	363	CTG	357	359	CTG	140;142;139	C;T;G	139;140;137	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:L121Q:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	691	2978	Escherichia_coli_EF_Tu	1185	1181	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1422	101.1	1	SNP	p	Q125R	0	.	.	373	375	CAG	369	371	CAG	138;138;135	C;A;G	137;133;135	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Q125R:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	691	2978	Escherichia_coli_EF_Tu	1185	1181	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1422	101.1	1	SNP	p	Q125E	0	.	.	373	375	CAG	369	371	CAG	138;138;135	C;A;G	137;133;135	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Q125E:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	691	2978	Escherichia_coli_EF_Tu	1185	1181	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1422	101.1	1	SNP	p	Q125K	0	.	.	373	375	CAG	369	371	CAG	138;138;135	C;A;G	137;133;135	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Q125K:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	691	2978	Escherichia_coli_EF_Tu	1185	1181	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1422	101.1	1	SNP	p	Y161D	0	.	.	481	483	TAC	477	479	TAC	124;126;130	T;A;C	124;126;130	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Y161D:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	691	2978	Escherichia_coli_EF_Tu	1185	1181	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1422	101.1	1	SNP	p	Y161N	0	.	.	481	483	TAC	477	479	TAC	124;126;130	T;A;C	124;126;130	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Y161N:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	691	2978	Escherichia_coli_EF_Tu	1185	1181	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1422	101.1	1	SNP	p	Y161C	0	.	.	481	483	TAC	477	479	TAC	124;126;130	T;A;C	124;126;130	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Y161C:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	691	2978	Escherichia_coli_EF_Tu	1185	1181	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1422	101.1	1	SNP	p	G317D	0	.	.	949	951	GGC	945	947	GGC	111;107;96	G;G;C,A	110;106;60,36	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:G317D:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	691	2978	Escherichia_coli_EF_Tu	1185	1181	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1422	101.1	1	SNP	p	A376V	0	.	.	1126	1128	GCA	1122	1124	GCA	110;110;109	G;C;A	107;106;108	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:A376V:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	691	2978	Escherichia_coli_EF_Tu	1185	1181	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1422	101.1	1	SNP	p	A376S	0	.	.	1126	1128	GCA	1122	1124	GCA	110;110;109	G;C;A	107;106;108	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:A376S:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	691	2978	Escherichia_coli_EF_Tu	1185	1181	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1422	101.1	1	SNP	p	E379K	0	.	.	1135	1137	GAA	1131	1133	GAA	113;111;112	G;A;A	112;110;111	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:E379K:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	691	2978	Escherichia_coli_EF_Tu	1185	1181	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1422	101.1	0	HET	.	.	.	T135C	.	135	135	T	131	131	T	74	T,C	47,22	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	691	2978	Escherichia_coli_EF_Tu	1185	1181	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1422	101.1	0	HET	.	.	.	C216T	.	216	216	C	212	212	C	108	C,T	63,43	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	691	2978	Escherichia_coli_EF_Tu	1185	1181	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1422	101.1	0	HET	.	.	.	C99T	.	99	99	C	95	95	C	75	C,T	46,28	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	1306	Escherichia_coli_mutant_1	1359	1359	99.85	Escherichia_coli_mutant_1.l6.c17.ctg.1	2044	33.5	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1665	1667	AAA	17;16;14	A;A;A	17;16;14	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	1554	Escherichia_coli_mutant	1392	1392	99.43	Escherichia_coli_mutant.l15.c4.ctg.1	1951	41.5	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1327	1329	GAA	55;54;54	G;A;A	55;54;54	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	358	H_NS	414	414	99.03	H_NS.l6.c4.ctg.1	970	19.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS;H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4164	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	774	141.8	0	.	n	.	0	T1041G	SNP	1041	1041	T	16	16	G	192	G	148	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4164	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	774	141.8	0	.	n	.	0	A1042T	SNP	1042	1042	A	17	17	T	201	T	158	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4164	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	774	141.8	0	.	n	.	0	A1136G	SNP	1136	1136	A	111	111	G	243	G,C	242,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4164	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	774	141.8	0	.	n	.	0	T1138C	SNP	1138	1138	T	113	113	C	226	C	225	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4164	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	774	141.8	0	.	n	.	0	T1142C	SNP	1142	1142	T	117	117	C	205	C	203	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4164	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	774	141.8	0	.	n	.	0	C1170T	SNP	1170	1170	C	145	145	T	191	T,A	190,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4164	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	774	141.8	0	.	n	.	0	T1220C	SNP	1220	1220	T	195	195	C	191	C	189	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4164	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	774	141.8	0	.	n	.	0	T1245C	SNP	1245	1245	T	220	220	C	155	C	154	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4164	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	774	141.8	0	.	n	.	0	G1253A	SNP	1253	1253	G	228	228	A	150	A,G	149,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4164	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	774	141.8	0	.	n	.	0	G1256A	SNP	1256	1256	G	231	231	A	154	A	153	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4164	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	774	141.8	0	.	n	.	0	C1258A	SNP	1258	1258	C	233	233	A	152	A	152	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4164	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	774	141.8	0	.	n	.	0	G1266T	SNP	1266	1266	G	241	241	T	155	T	152	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4164	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	774	141.8	0	.	n	.	0	T1267C	SNP	1267	1267	T	242	242	C	151	C	151	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4164	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	774	141.8	0	.	n	.	0	T1275C	SNP	1275	1275	T	250	250	C	133	C	133	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4164	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	774	141.8	0	.	n	.	0	G1276A	SNP	1276	1276	G	251	251	A	134	A	134	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4164	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	774	141.8	0	.	n	.	0	A1281G	SNP	1281	1281	A	256	256	G	128	G	128	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4164	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	774	141.8	0	.	n	.	0	T1283C	SNP	1283	1283	T	258	258	C	127	C	127	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4164	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	774	141.8	0	.	n	.	0	G1288T	SNP	1288	1288	G	263	263	T	147	T	147	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4164	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	774	141.8	0	.	n	.	0	A1296G	SNP	1296	1296	A	271	271	G	181	G	181	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4164	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	774	141.8	0	.	n	.	0	T1299G	SNP	1299	1299	T	274	274	G	195	G	195	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4164	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	774	141.8	0	.	n	.	0	A1300T	SNP	1300	1300	A	275	275	T	201	T	201	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4164	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	774	141.8	0	.	n	.	0	C1356T	SNP	1356	1356	C	331	331	T	199	T	197	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4164	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	774	141.8	0	.	n	.	0	A1358G	SNP	1358	1358	A	333	333	G	190	G	189	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4164	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	774	141.8	0	.	n	.	0	T1368C	SNP	1368	1368	T	343	343	C	145	C	145	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4164	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	774	141.8	0	.	n	.	0	G1370A	SNP	1370	1370	G	345	345	A	136	A	136	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4164	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	774	141.8	0	.	n	.	0	C1406.	DEL	1406	1406	C	380	380	C	97	C	96	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4164	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	774	141.8	0	.	n	.	0	.1409C	INS	1409	1409	T	384	384	C	91	C	91	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4164	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	774	141.8	0	.	n	.	0	C1431A	SNP	1431	1431	C	406	406	A	25	A	25	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4164	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	774	141.8	0	.	n	.	0	C1432A	SNP	1432	1432	C	407	407	A	25	A	25	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4164	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	774	141.8	0	.	n	.	0	A1441G	SNP	1441	1441	A	416	416	G	25	G	25	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4164	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	774	141.8	0	.	n	.	0	T1464C	SNP	1464	1464	T	439	439	C	28	C	28	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4164	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	774	141.8	0	.	n	.	0	G1473T	SNP	1473	1473	G	448	448	T	89	T	89	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4164	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	774	141.8	0	.	n	.	0	A1475G	SNP	1475	1475	A	450	450	G	101	G	98	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4164	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	774	141.8	0	.	n	.	0	A1548T	SNP	1548	1548	A	523	523	T	106	T	106	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4164	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	774	141.8	1	SNP	n	C1194G	0	.	.	1194	1194	C	169	169	C	208	C	208	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252:0:0:C1194G:.:Point mutations in the helix 34 region of 16S rRNA of Pasteurella multocida can confer resistance to spectinomycin	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4164	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	774	141.8	0	HET	.	.	.	C1040T	.	1040	1040	T	15	15	C	173	C,T	71,59	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1202	PmrB_1	1092	1092	99.08	PmrB_1.l15.c30.ctg.1	1673	38.0	0	.	p	.	0	H2R	NONSYN	4	6	CAT	295	297	CGT	39;39;38	C;G;T	38;38;38	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1202	PmrB_1	1092	1092	99.08	PmrB_1.l15.c30.ctg.1	1673	38.0	0	.	p	.	0	V30I	NONSYN	88	90	GTC	379	381	ATC	47;47;47	A;T;C	47;47;47	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1202	PmrB_1	1092	1092	99.08	PmrB_1.l15.c30.ctg.1	1673	38.0	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1138	1140	GGC	46;46;46	G;G;C	46;46;46	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1718	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2123	42.4	0	.	p	.	0	R8S	NONSYN	22	24	AGA	258	260	AGC	14;15;16	A;G;C	14;15;16	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1718	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2123	42.4	0	.	p	.	0	I142L	NONSYN	424	426	ATA	660	662	CTA	45;44;44	C;T;A	45;43;44	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1718	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2123	42.4	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1179	1181	CAA	69;72;72	C;A;A	69;72;72	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1718	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2123	42.4	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1278	1280	GGT	63;64;64	G;G;T	63;63;64	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1718	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2123	42.4	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1848	1850	GTT	26;24;23	G;T;T	26;24;23	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	758	PmrE	1167	1167	96.83	PmrE.l15.c4.ctg.1	1670	24.1	0	.	p	.	0	A125E	NONSYN	373	375	GCA	643	645	GAA	32;32;32	G;A;A	30;30;30	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	758	PmrE	1167	1167	96.83	PmrE.l15.c4.ctg.1	1670	24.1	0	.	p	.	0	M185T	NONSYN	553	555	ATG	823	825	ACC	16;16;16	A;C;C	16;16;16	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	758	PmrE	1167	1167	96.83	PmrE.l15.c4.ctg.1	1670	24.1	0	.	p	.	0	S225T	NONSYN	673	675	TCC	943	945	ACT	18;17;17	A;C;T	18;17;17	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	758	PmrE	1167	1167	96.83	PmrE.l15.c4.ctg.1	1670	24.1	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	1333	1335	ATC	15;16;15	A;T;C	15;16;14	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	27	986	PmrF	969	969	99.38	PmrF.l15.c4.ctg.1	1502	34.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrF
TEM_187.3001047.HM246246.211_1069.1956	TEM_187.3001047.HM246246.211_1069.1956	1	0	512	52	TEM_1+	858	148	99.32	TEM_1+.l6.c30.ctg.1	151	4.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TEM-187 is an extended-spectrum beta-lactamase found in P. mirabilis;TEM-187
TEM_187.3001047.HM246246.211_1069.1956	TEM_187.3001047.HM246246.211_1069.1956	1	0	512	52	TEM_1+	858	157	98.73	TEM_1+.l6.c30.ctg.2	157	2.9	0	.	p	.	0	V82I	NONSYN	244	246	GTT	25	27	ATT	1;1;2	A;T;T	1;1;2	.	TEM-187 is an extended-spectrum beta-lactamase found in P. mirabilis;TEM-187
TEM_187.3001047.HM246246.211_1069.1956	TEM_187.3001047.HM246246.211_1069.1956	1	0	512	52	TEM_1+	858	375	99.2	TEM_1+.l6.c30.ctg.3	377	2.0	0	.	p	.	0	H162R	NONSYN	484	486	CAT	106	108	CGT	3;3;3	C;G;T	3;3;3	.	TEM-187 is an extended-spectrum beta-lactamase found in P. mirabilis;TEM-187
aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	1	0	27	980	aad-	789	789	100.0	aad-.l15.c4.ctg.1	1380	37.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_007384.1 Shigella sonnei Ss046, complete genome
acrB.3000216.DQ679966.1515_4662.624	acrB.3000216.DQ679966.1515_4662.624	1	0	528	56	acrB	3147	144	92.36	acrB.l6.c30.ctg.2	150	7.1	0	.	p	.	0	N146D	NONSYN	436	438	AAC	136	138	GAT	1;1;1	G;A;T	1;1;1	.	acrB;Protein subunit of AcrA-AcrB-TolC multidrug efflux complex. AcrB functions as a herterotrimer which forms the inner membrane component and is primarily responsible for substrate recognition and energy transduction by acting as a drug/proton antiporter.
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	2860	acrD	3114	3114	99.07	acrD.l15.c4.ctg.1	3714	40.6	0	.	p	.	0	T85I	NONSYN	253	255	ACC	577	579	ATC	37;36;38	A;T;C	36;35;37	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	2860	acrD	3114	3114	99.07	acrD.l15.c4.ctg.1	3714	40.6	0	.	p	.	0	V253M	NONSYN	757	759	GTC	1081	1083	ATG	36;37;36	A;T;G	36;37;36	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	2860	acrD	3114	3114	99.07	acrD.l15.c4.ctg.1	3714	40.6	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2290	2292	AAG	39;40;42	A;A;G	38;40;42	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	1188	acrE	1158	1158	98.79	acrE.l6.c4.ctg.1	1777	35.2	0	.	p	.	0	A22V	NONSYN	64	66	GCC	372	374	GTC	20;21;22	G;T;C	20;21;22	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	1188	acrE	1158	1158	98.79	acrE.l6.c4.ctg.1	1777	35.2	0	.	p	.	0	S269C	NONSYN	805	807	AGC	1113	1115	TGC	50;50;52	T;G;C	49;50;52	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	656	2660	acrF	3105	2598	98.5	acrF.l15.c4.ctg.1	3224	43.3	0	.	p	.	0	S46trunc	TRUNC	136	136	T	488	488	T	32	T	31	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	656	2660	acrF	3105	2598	98.5	acrF.l15.c4.ctg.1	3224	43.3	0	.	p	.	0	G148D	NONSYN	442	444	GGC	794	796	GAC	42;43;42	G;A;C	42;43;42	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	656	2660	acrF	3105	2598	98.5	acrF.l15.c4.ctg.1	3224	43.3	0	.	p	.	0	F240L	NONSYN	718	720	TTT	1070	1072	TTA	35;35;33	T;T;A	34;35;33	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	656	2660	acrF	3105	2598	98.5	acrF.l15.c4.ctg.1	3224	43.3	0	.	p	.	0	D301N	NONSYN	901	903	GAT	1253	1255	AAT	34;35;35	A;A;T	32;35;34	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	656	2660	acrF	3105	2598	98.5	acrF.l15.c4.ctg.1	3224	43.3	0	.	p	.	0	L563fs	FSHIFT	1687	1687	T	2040	2040	T	72	T	71	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	656	2660	acrF	3105	2598	98.5	acrF.l15.c4.ctg.1	3224	43.3	0	HET	.	.	.	G186A	.	186	186	G	538	538	G	61	G,A	51,10	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	758	acrR_2	648	648	99.54	acrR_2.l15.c4.ctg.1	1167	34.3	1	SNP	p	R45C	0	.	.	133	135	CGC	384	386	CGC	56;55;56	C;G;C	56;55;56	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	626	acrS	663	663	98.64	acrS.l15.c30.ctg.1	1082	29.9	0	.	p	.	0	L34F	NONSYN	100	102	CTC	259	261	TTC	24;24;23	T;T;C	24;24;23	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	626	acrS	663	663	98.64	acrS.l15.c30.ctg.1	1082	29.9	0	.	p	.	0	E122G	NONSYN	364	366	GAG	523	525	GGG	35;34;34	G;G;G	35;34;33	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	868	adiY	762	762	99.61	adiY.l15.c30.ctg.1	1400	32.9	0	.	p	.	0	V136L	NONSYN	406	408	GTT	743	745	CTT	50;49;51	C;T;T	50;49;51	.	adiY;adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2964	alaS	2631	2631	98.86	alaS.l15.c4.ctg.1	3243	48.3	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2140	2142	GCA	73;74;78	G;C;A	73;74;77	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2964	alaS	2631	2631	98.86	alaS.l15.c4.ctg.1	3243	48.3	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2401	2403	ACC	58;58;57	A;C;C,G	53;57;55,1	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2964	alaS	2631	2631	98.86	alaS.l15.c4.ctg.1	3243	48.3	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2710	2712	GCC	35;36;39	G;C;C,G	35;36;38,1	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1426	arnA_1	1983	1983	98.29	arnA_1.l6.c30.ctg.1	2593	29.0	0	.	p	.	0	G37A	NONSYN	109	111	GGT	401	403	GCT	10;11;11	G;C;T	10;11;11	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1426	arnA_1	1983	1983	98.29	arnA_1.l6.c30.ctg.1	2593	29.0	0	.	p	.	0	D77E	NONSYN	229	231	GAT	521	523	GAG	7;8;8	G;A;G	7;8;8	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1426	arnA_1	1983	1983	98.29	arnA_1.l6.c30.ctg.1	2593	29.0	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	557	559	TGC	11;13;15	T;G;C	11;13;15	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1426	arnA_1	1983	1983	98.29	arnA_1.l6.c30.ctg.1	2593	29.0	0	.	p	.	0	I150V	NONSYN	448	450	ATT	740	742	GTT	21;21;22	G;T;T	21;21;22	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1426	arnA_1	1983	1983	98.29	arnA_1.l6.c30.ctg.1	2593	29.0	0	.	p	.	0	R200H	NONSYN	598	600	CGC	890	892	CAC	29;28;30	C;A;C	29;27;30	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1426	arnA_1	1983	1983	98.29	arnA_1.l6.c30.ctg.1	2593	29.0	0	.	p	.	0	T295M	NONSYN	883	885	ACG	1175	1177	ATG	55;56;55	A;T;G	53;55;53	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1426	arnA_1	1983	1983	98.29	arnA_1.l6.c30.ctg.1	2593	29.0	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	2171	2173	CGC	23;26;27	C;G;C	23;26;27	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	716	bacA	822	822	98.54	bacA.l6.c30.ctg.1	1299	28.8	0	.	p	.	0	S221T	NONSYN	661	663	AGC	920	922	ACC	11;12;15	A;C;C	11;12;15	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	716	bacA	822	822	98.54	bacA.l6.c30.ctg.1	1299	28.8	0	.	p	.	0	P225S	NONSYN	673	675	CCG	932	934	TCG	19;19;18	T;C;G	19;19;17	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	27	562	baeR	723	723	97.79	baeR.l15.c30.ctg.1	1187	24.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.;baeR
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1084	baeS	1404	1404	98.86	baeS.l15.c17.ctg.1	1931	29.5	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1417	1419	AAA	20;19;18	A;A;A	18;18;17	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1084	baeS	1404	1404	98.86	baeS.l15.c17.ctg.1	1931	29.5	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1429	1431	GAG	10;12;11	G;A;G	10;12;11	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1084	baeS	1404	1404	98.86	baeS.l15.c17.ctg.1	1931	29.5	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1435	1437	CAC	15;15;15	C;A;C	15;15;15	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1084	baeS	1404	1404	98.86	baeS.l15.c17.ctg.1	1931	29.5	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1489	1491	GAG	15;14;14	G;A;G	15;14;14	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	27	1380	cpxA	1374	1374	98.91	cpxA.l15.c4.ctg.1	1952	37.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.;cpxA
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	866	cpxR	699	699	99.43	cpxR.l6.c17.ctg.1	1173	38.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.;cpxR
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	539	840	cysB	975	975	99.28	cysB.l15.c4.ctg.1	1534	28.8	0	.	p	.	0	A146T	NONSYN	436	438	GCT	671	673	ACT	41;40;38	A;C;T	41;40;38	.	Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.;aminocoumarin resistant cysB
dfrA1.3002854.NC_010410.3676915_3677389.140	dfrA1.3002854.NC_010410.3676915_3677389.140	1	0	27	728	dfrA1_1	474	474	100.0	dfrA1_1.l6.c30.ctg.1	1060	36.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	dfrA1;dfrA1 is an integron-encoded dihydrofolate reductase found in Escherichia coli
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	1118	emrA	1173	1173	98.29	emrA.l6.c30.ctg.1	1758	33.5	0	.	p	.	0	I219V	NONSYN	655	657	ATC	968	970	GTC	55;53;52	G;T;C	51;53;52	.	EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.;emrA
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	539	1514	emrB	1539	1539	99.74	emrB.l6.c30.ctg.1	2202	36.1	0	.	p	.	0	E197K	NONSYN	589	591	GAA	942	944	AAA	37;39;38	A;A;A	37;39;38	.	emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.;emrB
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	1084	emrD	1191	1191	98.4	emrD.l15.c30.ctg.1	1524	36.4	0	.	p	.	0	G209S	NONSYN	625	627	GGC	873	875	AGC	25;24;23	A;G;C	25;24;23	.	emrD;EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	512	46	emrE_1	333	162	90.74	emrE_1.l6.c4.ctg.1	162	4.2	0	.	p	.	0	I100V	NONSYN	298	300	ATT	142	144	GTC	3;3;3	G;T;C	3;3;3	.	emrE;EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	512	46	emrE_1	333	83	96.39	emrE_1.l6.c4.ctg.2	153	7.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrE;EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	934	emrK	1056	1056	98.2	emrK.l15.c30.ctg.1	1783	27.8	0	.	p	.	0	K176R	NONSYN	526	528	AAG	887	889	AGG	32;32;33	A;G;G	32;32;33	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	934	emrK	1056	1056	98.2	emrK.l15.c30.ctg.1	1783	27.8	0	.	p	.	0	N306D	NONSYN	916	918	AAC	1277	1279	GAC	22;22;22	G;A;C	22;22;22	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	588	emrR	531	531	100.0	emrR.l6.c30.ctg.1	1151	26.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrR;EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	1458	emrY	1539	1539	99.81	emrY.l15.c30.ctg.1	2092	36.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY;emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	590	evgA	615	615	99.19	evgA.l15.c4.ctg.1	1188	26.5	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	474	476	CTG	23;23;23	C;T;G	23;23;23	.	evgA;EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2786	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4238	34.7	0	.	p	.	0	T38I	NONSYN	112	114	ACA	481	483	ATA	6;6;6	A;T;A	6;6;6	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2786	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4238	34.7	0	.	p	.	0	L42V	NONSYN	124	126	CTA	493	495	GTA	11;13;14	G;T;A	11;13;14	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2786	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4238	34.7	0	.	p	.	0	A93T	NONSYN	277	279	GCG	646	648	ACG	17;17;17	A;C;G	17;17;17	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2786	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4238	34.7	0	.	p	.	0	A114E	NONSYN	340	342	GCA	709	711	GAA	35;35;36	G;A;A	35;35;36	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2786	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4238	34.7	0	.	p	.	0	T127A	NONSYN	379	381	ACT	748	750	GCT	28;27;27	G;C;T	28;27;27	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2786	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4238	34.7	0	.	p	.	0	N133D	NONSYN	397	399	AAT	766	768	GAT	26;25;25	G;A;T	26;25;25	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2786	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4238	34.7	0	.	p	.	0	P162S	NONSYN	484	486	CCA	853	855	TCA	27;27;28	T;C;A	27;27;28	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2786	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4238	34.7	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	982	984	CAG	22;22;22	C;A;G	22;22;22	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2786	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4238	34.7	0	.	p	.	0	I251V	NONSYN	751	753	ATT	1120	1122	GTT	24;21;19	G;T;T	24;21;19	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2786	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4238	34.7	0	.	p	.	0	N303D	NONSYN	907	909	AAT	1276	1278	GAT	18;18;19	G;A;T	18;18;19	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2786	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4238	34.7	0	.	p	.	0	S359N	NONSYN	1075	1077	AGC	1444	1446	AAT	18;17;15	A;A;T	18;17;15	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2786	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4238	34.7	0	.	p	.	0	I366L	NONSYN	1096	1098	ATA	1465	1467	TTA	10;10;9	T;T;A	10;10;9	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2786	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4238	34.7	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	1666	1668	AAA	26;25;25	A;A;A	26;25;25	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2786	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4238	34.7	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	2401	2403	CAT	33;34;32	C;A;T	33;34;32	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2786	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4238	34.7	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	2455	2457	CAT	37;38;38	C;A;T	37;38;37	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2786	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4238	34.7	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	2473	2475	AGA	39;37;38	A;G;A	39;37;38	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2786	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4238	34.7	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	2488	2490	AAT	41;42;42	A;A;T	41;42;42	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2786	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4238	34.7	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	2635	2637	TCC	27;26;26	T;C;C	27;26;26	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2786	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4238	34.7	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	2800	2802	ATT	38;38;35	A;T;T	38;38;35	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2786	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4238	34.7	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	2821	2823	GAT	41;42;43	G;A;T	40;41;43	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2786	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4238	34.7	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	2935	2937	GTT	48;47;46	G;T;T	48;47;46	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2786	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4238	34.7	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	3220	3222	CAC	53;53;53	C;A;C	53;51;52	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	880	folP_1	849	849	99.29	folP_1.l15.c17.ctg.1	1276	36.0	1	SNP	p	P64H	0	.	.	190	192	CCA	357	359	CCA	56;58;58	C,A;C;A	55,1;58;58	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	880	folP_1	849	849	99.29	folP_1.l15.c17.ctg.1	1276	36.0	1	SNP	p	P64A	0	.	.	190	192	CCA	357	359	CCA	56;58;58	C,A;C;A	55,1;58;58	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	880	folP_1	849	849	99.29	folP_1.l15.c17.ctg.1	1276	36.0	1	SNP	p	P64S	0	.	.	190	192	CCA	357	359	CCA	56;58;58	C,A;C;A	55,1;58;58	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	880	folP_1	849	849	99.29	folP_1.l15.c17.ctg.1	1276	36.0	1	SNP	p	P64R	0	.	.	190	192	CCA	357	359	CCA	56;58;58	C,A;C;A	55,1;58;58	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	880	folP_1	849	849	99.29	folP_1.l15.c17.ctg.1	1276	36.0	1	SNP	p	P64L	0	.	.	190	192	CCA	357	359	CCA	56;58;58	C,A;C;A	55,1;58;58	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	644	gadE	528	528	100.0	gadE.l15.c4.ctg.1	1168	29.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.;gadE
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	166	gadW	729	247	95.95	gadW.l15.c4.ctg.1	451	13.0	0	.	p	.	0	S234A	NONSYN	700	702	TCG	218	220	GCG	9;9;9	G;C;G	9;9;9	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	166	gadW	729	384	93.49	gadW.l15.c4.ctg.2	384	7.6	0	.	p	.	0	L31V	NONSYN	91	93	CTG	16	18	GTG	1;1;1	G;T;G	1;1;1	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	166	gadW	729	384	93.49	gadW.l15.c4.ctg.2	384	7.6	0	.	p	.	0	D34E	NONSYN	100	102	GAT	25	27	GAG	1;1;1	G;A;G	1;1;1	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	166	gadW	729	384	93.49	gadW.l15.c4.ctg.2	384	7.6	0	.	p	.	0	L46P	NONSYN	136	138	CTG	61	63	CCG	5;5;5	C;C;G	5;5;5	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	166	gadW	729	384	93.49	gadW.l15.c4.ctg.2	384	7.6	0	.	p	.	0	E54D	NONSYN	160	162	GAA	85	87	GAT	10;10;10	G;A;T	10;10;10	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	166	gadW	729	384	93.49	gadW.l15.c4.ctg.2	384	7.6	0	.	p	.	0	I88M	NONSYN	262	264	ATA	187	189	ATG	4;4;4	A;T;G	4;4;4	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	166	gadW	729	384	93.49	gadW.l15.c4.ctg.2	384	7.6	0	.	p	.	0	Q89P	NONSYN	265	267	CAG	190	192	CCG	3;3;3	C;C;G	3;3;3	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	166	gadW	729	384	93.49	gadW.l15.c4.ctg.2	384	7.6	0	.	p	.	0	D100E	NONSYN	298	300	GAC	223	225	GAA	5;5;5	G;A;A	5;5;5	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	166	gadW	729	384	93.49	gadW.l15.c4.ctg.2	384	7.6	0	.	p	.	0	P101S	NONSYN	301	303	CCC	226	228	TCC	5;5;6	T;C;C	5;5;6	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	166	gadW	729	384	93.49	gadW.l15.c4.ctg.2	384	7.6	0	.	p	.	0	R102G	NONSYN	304	306	CGG	229	231	GGG	7;6;6	G;G;G	7;6;6	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	166	gadW	729	384	93.49	gadW.l15.c4.ctg.2	384	7.6	0	.	p	.	0	K110N	NONSYN	328	330	AAA	253	255	AAT	6;6;7	A;A;T	6;6;7	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	688	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1359	26.7	0	.	p	.	0	F53L	NONSYN	157	159	TTC	425	427	TTA	41;40;39	T;T;A	41;40;39	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	688	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1359	26.7	0	.	p	.	0	V79I	NONSYN	235	237	GTT	503	505	ATT	27;27;28	A;T;T	27;27;28	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	688	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1359	26.7	0	.	p	.	0	R246G	NONSYN	736	738	AGA	1004	1006	GGA	24;22;22	G;G,T;A	23;21,1;22	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	688	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1359	26.7	0	.	p	.	0	S248P	NONSYN	742	744	TCG	1010	1012	CCG	21;22;22	C;C;G	21;22;22	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2730	gyrA_7	2628	2628	98.71	gyrA_7.l6.c4.ctg.1	3273	44.2	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2361	2363	GAA	51;51;51	G;A;A	51;51;50	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2730	gyrA_7	2628	2628	98.71	gyrA_7.l6.c4.ctg.1	3273	44.2	1	SNP	p	S83L	0	.	.	247	249	TCG	576	578	TCG	57;57;58	T;C;G	55;57;58	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2730	gyrA_7	2628	2628	98.71	gyrA_7.l6.c4.ctg.1	3273	44.2	1	SNP	p	S83W	0	.	.	247	249	TCG	576	578	TCG	57;57;58	T;C;G	55;57;58	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2730	gyrA_7	2628	2628	98.71	gyrA_7.l6.c4.ctg.1	3273	44.2	1	SNP	p	S83I	0	.	.	247	249	TCG	576	578	TCG	57;57;58	T;C;G	55;57;58	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2730	gyrA_7	2628	2628	98.71	gyrA_7.l6.c4.ctg.1	3273	44.2	1	SNP	p	D87V	0	.	.	259	261	GAC	588	590	GAC	53;53;53	G;A;C	52;52;53	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2730	gyrA_7	2628	2628	98.71	gyrA_7.l6.c4.ctg.1	3273	44.2	1	SNP	p	D87H	0	.	.	259	261	GAC	588	590	GAC	53;53;53	G;A;C	52;52;53	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2730	gyrA_7	2628	2628	98.71	gyrA_7.l6.c4.ctg.1	3273	44.2	1	SNP	p	D87G	0	.	.	259	261	GAC	588	590	GAC	53;53;53	G;A;C	52;52;53	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2730	gyrA_7	2628	2628	98.71	gyrA_7.l6.c4.ctg.1	3273	44.2	1	SNP	p	D87N	0	.	.	259	261	GAC	588	590	GAC	53;53;53	G;A;C	52;52;53	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2730	gyrA_7	2628	2628	98.71	gyrA_7.l6.c4.ctg.1	3273	44.2	1	SNP	p	D87Y	0	.	.	259	261	GAC	588	590	GAC	53;53;53	G;A;C	52;52;53	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2424	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	3000	42.5	1	SNP	p	R136H	0	.	.	406	408	CGC	735	737	CGC	43;41;41	C;G;C	43;41;41	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2424	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	3000	42.5	1	SNP	p	R136C	0	.	.	406	408	CGC	735	737	CGC	43;41;41	C;G;C	43;41;41	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2424	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	3000	42.5	1	SNP	p	R136I	0	.	.	406	408	CGC	735	737	CGC	43;41;41	C;G;C	43;41;41	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2424	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	3000	42.5	1	SNP	p	R136E	0	.	.	406	408	CGC	735	737	CGC	43;41;41	C;G;C	43;41;41	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2424	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	3000	42.5	1	SNP	p	R136S	0	.	.	406	408	CGC	735	737	CGC	43;41;41	C;G;C	43;41;41	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2424	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	3000	42.5	1	SNP	p	R136G	0	.	.	406	408	CGC	735	737	CGC	43;41;41	C;G;C	43;41;41	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2424	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	3000	42.5	1	SNP	p	R136L	0	.	.	406	408	CGC	735	737	CGC	43;41;41	C;G;C	43;41;41	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	568	kdpE	678	678	98.23	kdpE.l15.c4.ctg.1	1151	26.0	0	.	p	.	0	A72P	NONSYN	214	216	GCG	462	464	CCG	32;32;34	C;C;G	32;32;34	.	kdpE;kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	568	kdpE	678	678	98.23	kdpE.l15.c4.ctg.1	1151	26.0	0	.	p	.	0	T123A	NONSYN	367	369	ACC	615	617	GCC	25;26;26	G;C;C	24;26;26	.	kdpE;kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	1132	leuO	945	945	99.26	leuO.l15.c4.ctg.1	1545	38.4	0	.	p	.	0	P9S	NONSYN	25	27	CCA	291	293	TCA	26;25;25	T;C;A	25;25;25	.	leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.;leuO
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	358	marA	384	384	99.74	marA.l15.c4.ctg.1	960	19.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.;marA
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	260	marR	435	435	97.47	marR.l15.c4.ctg.2	743	17.6	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	604	606	AGC	18;15;16	A;G;C	18;15;16	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	260	marR	435	435	97.47	marR.l15.c4.ctg.2	743	17.6	1	SNP	p	Y137H	1	Y137H	NONSYN	409	411	TAT	706	708	CAT	12;11;11	C;A;T	8;6;10	marR.3003378.U00096.1619119_1619554.2097:1:1:Y137H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	260	marR	435	435	97.47	marR.l15.c4.ctg.2	743	17.6	0	.	p	.	0	V142A	NONSYN	424	426	GTC	721	723	GCC	8;6;6	G;C,T;C	7;1,1;6	.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	260	marR	435	435	97.47	marR.l15.c4.ctg.2	743	17.6	1	SNP	p	V45E	0	.	.	133	135	GTG	430	432	GTG	43;42;42	G;T;G	43;42;42	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	260	marR	435	435	97.47	marR.l15.c4.ctg.2	743	17.6	1	SNP	p	I49S	0	.	.	145	147	ATC	442	444	ATC	38;38;38	A;T;C	38;37;37	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	260	marR	435	435	97.47	marR.l15.c4.ctg.2	743	17.6	1	SNP	p	A70T	0	.	.	208	210	GCA	505	507	GCA	33;33;33	G;C;A	33;33;33	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	260	marR	435	435	97.47	marR.l15.c4.ctg.2	743	17.6	1	SNP	p	R73C	0	.	.	217	219	CGT	514	516	CGT	31;27;27	C;G;T	31;26;27	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	260	marR	435	435	97.47	marR.l15.c4.ctg.2	743	17.6	1	SNP	p	R73S	0	.	.	217	219	CGT	514	516	CGT	31;27;27	C;G;T	31;26;27	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	260	marR	435	435	97.47	marR.l15.c4.ctg.2	743	17.6	1	SNP	p	R77L	0	.	.	229	231	CGC	526	528	CGC	28;26;26	C;G;C	28;26;26	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	260	marR	435	435	97.47	marR.l15.c4.ctg.2	743	17.6	1	SNP	p	R77C	0	.	.	229	231	CGC	526	528	CGC	28;26;26	C;G;C	28;26;26	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	260	marR	435	435	97.47	marR.l15.c4.ctg.2	743	17.6	1	SNP	p	L78M	0	.	.	232	234	CTG	529	531	CTG	25;25;23	C;T;G	25;25;23	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	260	marR	435	435	97.47	marR.l15.c4.ctg.2	743	17.6	1	SNP	p	R94H	0	.	.	280	282	CGC	577	579	CGC	9;8;9	C;G;C	9;8;9	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	260	marR	435	435	97.47	marR.l15.c4.ctg.2	743	17.6	1	SNP	p	R94S	0	.	.	280	282	CGC	577	579	CGC	9;8;9	C;G;C	9;8;9	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	260	marR	435	435	97.47	marR.l15.c4.ctg.2	743	17.6	1	SNP	p	V96E	0	.	.	286	288	GTA	583	585	GTA	10;12;13	G;T;A	10;12;13	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	732	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1540	24.7	0	.	p	.	0	S7F	NONSYN	19	21	TCC	55	57	TTC	9;9;9	T;T;C	9;9;9	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	732	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1540	24.7	0	.	p	.	0	R36I	NONSYN	106	108	AGG	142	144	ATC	17;17;17	A;T,C;C	17;15,1;16	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	732	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1540	24.7	0	.	p	.	0	E42A	NONSYN	124	126	GAA	160	162	GCC	10;10;10	G;C;C	9;10;10	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	732	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1540	24.7	0	.	p	.	0	N43V	NONSYN	127	129	AAT	163	165	GTG	10;10;10	G;T,A;G	10;9,1;10	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	732	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1540	24.7	0	.	p	.	0	E52D	NONSYN	154	156	GAG	190	192	GAT	13;13;13	G;A;T	13;13;13	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	732	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1540	24.7	0	.	p	.	0	N59T	NONSYN	175	177	AAC	211	213	ACC	12;11;11	A;C;C	12;11;11	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	732	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1540	24.7	0	.	p	.	0	I68L	NONSYN	202	204	ATA	238	240	TTA	13;13;12	T;T;A	13;13;12	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	732	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1540	24.7	0	.	p	.	0	H115Q	NONSYN	343	345	CAC	379	381	CAG	38;38;38	C;A;G,T	38;38;36,1	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	732	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1540	24.7	0	.	p	.	0	D128A	NONSYN	382	384	GAC	418	420	GCC	28;28;28	G;C;C	28;28;28	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	732	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1540	24.7	0	.	p	.	0	S163A	NONSYN	487	489	TCG	523	525	GCG	29;32;33	G;C;G	29;32;33	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	732	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1540	24.7	0	.	p	.	0	L231V	NONSYN	691	693	CTT	727	729	GTT	17;19;19	G;T;T	11;17;16	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	732	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1540	24.7	0	.	p	.	0	R285fs	FSHIFT	853	853	C	889	889	C	31	C	31	.	mdfA;Multidrug translocase MdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	842	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1520	27.7	0	.	p	.	0	V12trunc	TRUNC	34	34	G	73	73	G	45	G	45	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	842	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1520	27.7	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	130	132	CAG	19;19;18	C;A;G	19;19;17	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	842	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1520	27.7	0	.	p	.	0	T83I	NONSYN	247	249	ACC	280	282	ATC	18;18;17	A;T;C	18;18;17	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	842	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1520	27.7	0	.	p	.	0	I99M	NONSYN	295	297	ATA	328	330	ATG	19;20;20	A;T;G	18;20;20	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	842	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1520	27.7	0	.	p	.	0	A130T	NONSYN	388	390	GCC	421	423	ACC	29;30;31	A;C;C	28;29;30	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	842	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1520	27.7	0	.	p	.	0	P257T	NONSYN	769	771	CCG	802	804	ACG	21;20;21	A;C;G	20;19;21	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2570	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3599	37.5	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	2093	2095	ACC	56;56;54	A,T;C;C	55,1;56;54	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2570	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3599	37.5	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2486	2488	CAA	32;33;33	C;A;A	31;33;32	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2570	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3599	37.5	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2654	2656	ATT	23;23;23	A;T;T	22;22;23	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2570	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3599	37.5	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2738	2740	GTT	32;32;32	G;T;T	32;31;32	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2570	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3599	37.5	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2846	2848	GAG	32;30;30	G;A;G	31;30;29	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2570	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3599	37.5	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	3074	3076	ATG	29;28;29	A;T;G	29;28;29	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2570	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3599	37.5	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3209	3211	GAT	41;41;40	G;A;T	40;41;40	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2430	mdtC	3078	3078	98.64	mdtC.l15.c17.ctg.1	3297	38.4	0	.	p	.	0	I46M	NONSYN	136	138	ATC	323	325	ATG	15;18;18	A;T;G	15;18;18	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2430	mdtC	3078	3078	98.64	mdtC.l15.c17.ctg.1	3297	38.4	0	.	p	.	0	V208I	NONSYN	622	624	GTC	809	811	ATC	38;41;42	A;T;C	38;41;42	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2430	mdtC	3078	3078	98.64	mdtC.l15.c17.ctg.1	3297	38.4	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	3125	3127	CAC	6;6;7	C;A;C	6;5;7	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2430	mdtC	3078	3078	98.64	mdtC.l15.c17.ctg.1	3297	38.4	0	.	p	.	0	P981L	NONSYN	2941	2943	CCC	3128	3130	CTC	7;7;7	C;T;C	7;7;7	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1146	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1948	30.6	0	.	p	.	0	D3E	NONSYN	7	9	GAT	189	191	GAA	20;19;19	G;A;A	20;19;19	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1146	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1948	30.6	0	.	p	.	0	T226A	NONSYN	676	678	ACG	858	860	GCG	35;35;35	G,T;C;G	34,1;35;35	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1146	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1948	30.6	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1200	1202	ATC	37;37;38	A;T;C	37;37;37	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1146	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1948	30.6	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1503	1505	TTT	40;40;40	T;T;T	40;40;40	.	mdtD;Efflux pump mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	1314	mdtE	1158	1158	99.31	mdtE.l15.c30.ctg.1	1816	38.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtE;MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	3316	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3647	47.9	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1152	1154	ACC	40;40;38	A;C,A;C	40;34,3;37	.	mdtF;MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	3316	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3647	47.9	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2394	2396	GAC	64;65;65	G;A;C	61;62;63	.	mdtF;MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	1148	mdtG	1227	1047	99.33	mdtG.l15.c30.ctg.1	1682	30.2	0	.	p	.	0	V200I	NONSYN	598	600	GTC	724	726	ATC	39;39;41	A;T;C	39;39;41	.	mdtG;Efflux protien mdtG.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	1148	mdtG	1227	182	99.45	mdtG.l15.c30.ctg.2	387	17.5	0	.	p	.	0	E5G	NONSYN	13	15	GAA	210	212	GGA	15;13;14	G;G;A	15;13;14	.	mdtG;Efflux protien mdtG.
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	982	mdtH	1209	1209	98.18	mdtH.l6.c30.ctg.1	1722	30.0	0	.	p	.	0	G134C	NONSYN	400	402	GGT	658	660	TGT	55;55;56	T;G;T	54;55;55	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	982	mdtH	1209	1209	98.18	mdtH.l6.c30.ctg.1	1722	30.0	0	.	p	.	0	S324L	NONSYN	970	972	TCG	1228	1230	TTG	31;31;32	T;T;G	31;30;32	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	982	mdtH	1209	1209	98.18	mdtH.l6.c30.ctg.1	1722	30.0	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1438	1440	ACG	15;15;15	A;C;G	15;15;15	.	mdtH;Multidrug resistance protein MdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	1252	mdtL	1176	1176	98.38	mdtL.l6.c4.ctg.1	1806	36.5	0	.	p	.	0	A185S	NONSYN	553	555	GCC	907	909	TCC	39;40;38	T;C;C	36;40;38	.	Multidrug resistance protein MdtL;mdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	868	mdtN	1032	1032	98.06	mdtN.l6.c17.ctg.1	1629	28.0	0	.	p	.	0	V119I	NONSYN	355	357	GTT	645	647	ATT	33;32;32	A;T;T	33;32;32	.	mdtN;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1920	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2655	38.2	0	.	p	.	0	V11M	NONSYN	31	33	GTG	323	325	ATG	23;24;26	A;T;G	22;24;26	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1920	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2655	38.2	0	.	p	.	0	T33I	NONSYN	97	99	ACC	389	391	ATC	20;19;19	A;T;C	20;19;19	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1920	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2655	38.2	0	.	p	.	0	C116R	NONSYN	346	348	TGC	638	640	CGC	55;56;52	C;G;C	55;56;51	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1920	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2655	38.2	0	.	p	.	0	N238S	NONSYN	712	714	AAC	1004	1006	AGC	37;36;36	A;G;C	37;35;36	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1920	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2655	38.2	0	.	p	.	0	M305V	NONSYN	913	915	ATG	1205	1207	GTG	32;34;32	G;T;G,T	32;31;31,1	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1920	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2655	38.2	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1268	1270	AAC	28;27;26	A;A;C	25;24;23	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1920	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2655	38.2	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	1313	1315	GTC	41;41;40	G;T;C	40;39;40	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1920	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2655	38.2	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1343	1345	ATA	46;45;44	A;T;A	46;45;44	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1920	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2655	38.2	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1451	1453	TCT	43;44;45	T;C;T	43;44;45	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1920	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2655	38.2	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1838	1840	GCG	50;50;48	G;C;G	49;47;46	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1920	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2655	38.2	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	2051	2053	ATC	44;42;43	A;T;C	44;42;43	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1302	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1969	34.8	0	.	p	.	0	S129A	NONSYN	385	387	TCA	634	636	GCG	32;32;33	G;C;G	31;32;32	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1302	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1969	34.8	0	.	p	.	0	A187T	NONSYN	559	561	GCC	808	810	ACC	39;40;40	A;C;C	39;40;40	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1302	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1969	34.8	0	.	p	.	0	H211R	NONSYN	631	633	CAC	880	882	CGC	44;44;45	C;G;C	44;44;45	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1302	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1969	34.8	0	.	p	.	0	V250A	NONSYN	748	750	GTT	997	999	GCT	46;45;43	G;C;T	46;43;43	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1302	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1969	34.8	0	.	p	.	0	R278K	NONSYN	832	834	AGA	1081	1083	AAA	19;20;21	A;A;A	19;20;21	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1302	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1969	34.8	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	1099	1101	CGA	29;30;30	C;G;A	29;30;30	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1302	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1969	34.8	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1264	1266	GCC	28;28;28	G;C;C	27;26;28	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1302	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1969	34.8	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1276	1278	GAT	37;39;41	G;A;T	37;39;41	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1302	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1969	34.8	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1693	1695	GCT	18;18;18	G;C;T	17;17;17	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	2892	mfd	3447	3447	99.16	mfd.l6.c17.ctg.1	4038	37.7	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1662	1664	AAG	41;41;43	A;A;G	40;41;43	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	2892	mfd	3447	3447	99.16	mfd.l6.c17.ctg.1	4038	37.7	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2739	2741	CTG	32;32;32	C;T;G	31;31;32	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	27	208	mgrB	144	144	100.0	mgrB.l15.c30.ctg.2	168	33.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB;mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1824	msbA	1749	1749	98.68	msbA.l15.c30.ctg.1	2237	43.0	0	.	p	.	0	S278N	NONSYN	832	834	AGC	1030	1032	AAC	44;42;42	A;A;C	42;42;42	.	msbA;MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1824	msbA	1749	1749	98.68	msbA.l15.c30.ctg.1	2237	43.0	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1576	1578	ATA	63;64;62	A;T;A	61;63;60	.	msbA;MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	1358	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.1	1816	39.4	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1400	1402	GAT	69;69;71	G;A;T	69;69;70	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	1358	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.1	1816	39.4	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1403	1405	CTG	71;70;71	C;T;G	70;70;71	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	545	694	nfsA	723	88	97.73	nfsA.l15.c4.ctg.1	88	18.4	0	.	p	.	0	R27C	NONSYN	79	81	CGT	6	8	TGT	10;11;13	T;G;T	10;11;13	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	545	694	nfsA	723	88	97.73	nfsA.l15.c4.ctg.1	88	18.4	1	SNP	p	S33R	0	.	.	97	99	AGC	24	26	AGC	27;28;28	A;G;C	27;28;28	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	545	694	nfsA	723	558	99.28	nfsA.l15.c4.ctg.2	1054	27.0	0	.	p	.	0	I117T	NONSYN	349	351	ATC	383	385	ACC	30;32;32	A;C;C	29;32;32	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	545	694	nfsA	723	558	99.28	nfsA.l15.c4.ctg.2	1054	27.0	0	.	p	.	0	G187D	NONSYN	559	561	GGC	593	595	GAC	35;33;33	G;A;C	35;33;33	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	545	694	nfsA	723	558	99.28	nfsA.l15.c4.ctg.2	1054	27.0	1	SNP	p	G131D	0	.	.	391	393	GGC	425	427	GGC	45;47;46	G;G;C	45;45;44	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	545	694	nfsA	723	558	99.28	nfsA.l15.c4.ctg.2	1054	27.0	1	SNP	p	R203L	0	.	.	607	609	CGT	641	643	CGT	43;43;42	C;G;T	43;43;42	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203L:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	545	694	nfsA	723	558	99.28	nfsA.l15.c4.ctg.2	1054	27.0	1	SNP	p	R203C	0	.	.	607	609	CGT	641	643	CGT	43;43;42	C;G;T	43;43;42	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	545	694	nfsA	723	87	98.85	nfsA.l15.c4.ctg.5	99	24.0	0	.	p	.	0	R27C	NONSYN	79	81	CGT	91	93	TGT	11;8;8	T;G;T	11;8;8	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	545	694	nfsA	723	87	98.85	nfsA.l15.c4.ctg.5	99	24.0	1	SNP	p	R15C	0	.	.	43	45	CGC	55	57	CGC	43;40;40	C;G;C	43;40;40	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1304	ompF	1089	1089	99.91	ompF.l6.c4.ctg.1	1714	40.3	0	.	p	.	0	D312E	NONSYN	934	936	GAT	1238	1240	GAG	45;46;45	G;A;G,T	45;46;44,1	.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1304	ompF	1089	1089	99.91	ompF.l6.c4.ctg.1	1714	40.3	1	SNP	p	G141D	0	.	.	421	423	GGT	725	727	GGT	64;65;65	G;G;T	64;65;65	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1304	ompF	1089	1089	99.91	ompF.l6.c4.ctg.1	1714	40.3	1	SNP	p	G141E	0	.	.	421	423	GGT	725	727	GGT	64;65;65	G;G;T	64;65;65	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1304	ompF	1089	1089	99.91	ompF.l6.c4.ctg.1	1714	40.3	1	SNP	p	R154D	0	.	.	460	462	CGT	764	766	CGT	52;55;56	C;G;T	52;55;56	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1304	ompF	1089	1089	99.91	ompF.l6.c4.ctg.1	1714	40.3	1	SNP	p	R154A	0	.	.	460	462	CGT	764	766	CGT	52;55;56	C;G;T	52;55;56	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2488	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2827	46.2	0	.	p	.	0	A533V	NONSYN	1597	1599	GCG	1928	1930	GTG	61;61;61	G;T;G	61;61;61	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2488	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2827	46.2	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1955	1957	TCG	59;58;60	T,A;C;G	50,1;53;55	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2488	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2827	46.2	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2570	2572	AAC	25;21;22	A;A;C	25;21;22	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2488	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2827	46.2	1	SNP	p	A85T	0	.	.	253	255	GCG	584	586	GCG	53;52;52	G;C,T;G,A	51;50,1;51,1	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2488	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2827	46.2	1	SNP	p	D111H	0	.	.	331	333	GAT	662	664	GAT	61;61;61	G;A;T	61;61;60	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2488	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2827	46.2	1	SNP	p	S129P	0	.	.	385	387	TCC	716	718	TCC	43;43;42	T;C;C	42;43;41	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	1508	parE_1	1893	1893	97.52	parE_1.l6.c30.ctg.1	2430	32.9	0	.	p	.	0	D473N	NONSYN	1417	1419	GAC	1718	1720	AAC	42;42;41	A;A;C	42;41;41	.	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	1508	parE_1	1893	1893	97.52	parE_1.l6.c30.ctg.1	2430	32.9	1	SNP	p	D476N	0	.	.	1426	1428	GAT	1727	1729	GAT	52;52;52	G;A;T	52;52;52	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	1554	patA	1380	1380	99.78	patA.l15.c30.ctg.1	2035	40.2	0	.	p	.	0	P202Q	NONSYN	604	606	CCG	947	949	CAG	54;54;57	C;A;G	53;53;56	.	PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.;patA
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	1554	patA	1380	1380	99.78	patA.l15.c30.ctg.1	2035	40.2	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1421	1423	GAT	38;37;36	G;A;T	38;37;36	.	PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.;patA
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4604	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4562	53.1	1	SNP	p	V146F	0	.	.	436	438	GTT	695	697	GTT	66;63;62	G;T;T	66;63;62	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4604	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4562	53.1	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1796	1798	CAG	46;47;48	C;A;G	46;47;48	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4604	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4562	53.1	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1796	1798	CAG	46;47;48	C;A;G	46;47;48	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4604	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4562	53.1	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1835	1837	CAC	59;56;56	C;A;C	59;56;56	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4604	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4562	53.1	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1844	1846	CGT	52;51;49	C;G;T	52;51;49	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4604	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4562	53.1	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1844	1846	CGT	52;51;49	C;G;T	52;51;49	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4604	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4562	53.1	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1850	1852	TCC	49;48;47	T;C;C	49;48;46	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4604	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4562	53.1	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1856	1858	CTC	46;47;49	C;T;C	46;47;49	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4604	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4562	53.1	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1946	1948	ACC	50;50;52	A;C;C	50;50;52	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4604	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4562	53.1	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1949	1951	CCT	51;53;52	C;C;T	51;53;52	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4604	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4562	53.1	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2318	2320	CGT	98;97;93	C;G;T	96;94;90	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12122	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.1	1118	325.1	0	.	n	.	0	A226G	SNP	226	226	A	343	343	G	379	G	379	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12122	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.1	1118	325.1	1	SNP	n	A794T	0	.	.	794	794	A	911	911	A	361	A	359	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12122	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.1	1118	325.1	1	SNP	n	A794G	0	.	.	794	794	A	911	911	A	361	A	359	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12122	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.1	1118	325.1	1	SNP	n	G926A	0	.	.	926	926	G	1043	1043	G	344	G,T	337,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12122	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.1	1118	325.1	1	SNP	n	G926C	0	.	.	926	926	G	1043	1043	G	344	G,T	337,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12122	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.1	1118	325.1	1	SNP	n	G926T	0	.	.	926	926	G	1043	1043	G	344	G,T	337,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12122	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.1	1118	325.1	0	HET	.	.	.	C719T	.	719	719	C	836	836	C	348	C,T	196,149	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12122	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.1	1118	325.1	0	HET	.	.	.	A79G	.	79	79	A	196	196	A	330	A,G	251,76	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12122	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.1	1118	325.1	0	HET	.	.	.	C183T	.	183	183	C	300	300	C	306	C,T	209,93	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12122	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.1	1118	325.1	0	HET	.	.	.	T90C	.	90	90	T	207	207	T	323	T,C	253,64	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12122	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.1	1118	325.1	0	HET	.	.	.	G474A,C	.	474	474	G	591	591	G	384	G,A,C	241,138,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12122	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.1	1118	325.1	0	HET	.	.	.	C194T	.	194	194	C	311	311	C	308	C,T	246,61	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12122	rrsB+	1542	503	100.0	rrsB+.l15.c17.ctg.2	517	384.8	1	SNP	n	A1519C	0	.	.	1519	1519	A	480	480	A	236	A	231	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12122	rrsB+	1542	503	100.0	rrsB+.l15.c17.ctg.2	517	384.8	1	SNP	n	A1519G	0	.	.	1519	1519	A	480	480	A	236	A	231	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12122	rrsB+	1542	503	100.0	rrsB+.l15.c17.ctg.2	517	384.8	1	SNP	n	A1519T	0	.	.	1519	1519	A	480	480	A	236	A	231	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12122	rrsB+	1542	142	100.0	rrsB+.l15.c17.ctg.3	142	81.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12122	rrsB+	1542	140	95.04	rrsB+.l15.c17.ctg.6	140	67.3	0	.	n	.	0	G1002A	SNP	1002	1002	G	54	54	A	113	A,G	112,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12122	rrsB+	1542	140	95.04	rrsB+.l15.c17.ctg.6	140	67.3	0	.	n	.	0	G1006C	SNP	1006	1006	G	58	58	C	121	C,G	118,2	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12122	rrsB+	1542	140	95.04	rrsB+.l15.c17.ctg.6	140	67.3	0	.	n	.	0	T1010C	SNP	1010	1010	T	62	62	C	120	C,T	118,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12122	rrsB+	1542	140	95.04	rrsB+.l15.c17.ctg.6	140	67.3	0	.	n	.	0	A1019.	DEL	1019	1019	A	70	70	G	120	G	119	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12122	rrsB+	1542	140	95.04	rrsB+.l15.c17.ctg.6	140	67.3	0	.	n	.	0	.1023G	INS	1023	1023	T	75	75	G	115	G,T	114,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12122	rrsB+	1542	140	95.04	rrsB+.l15.c17.ctg.6	140	67.3	0	.	n	.	0	C1038T	SNP	1038	1038	C	90	90	T	103	T	103	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
sat_1.3002895.AB211124.0_525.584	sat_1.3002895.AB211124.0_525.584	1	0	27	684	sat_1	525	525	100.0	sat_1.l15.c30.ctg.1	1123	32.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	sat-1 is a plasmid-mediated streptothricin acetyltransferase in Escherichia coli;sat-1
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	608	soxR	465	465	100.0	soxR.l15.c4.ctg.1	908	35.6	1	SNP	p	R20H	0	.	.	58	60	CGC	260	262	CGC	55;59;59	C;G;C	55;59;59	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	608	soxR	465	465	100.0	soxR.l15.c4.ctg.1	908	35.6	1	SNP	p	G121D	0	.	.	361	363	GGT	563	565	GGT	54;55;53	G;G,T;T	54;53,1;52	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	426	soxS_1	324	324	99.69	soxS_1.l15.c30.ctg.1	924	24.3	1	SNP	p	A12S	0	.	.	34	36	GCA	358	360	GCA	43;45;46	G;C;A	43;45;46	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
strA.manually_added_NC_009345_WP_001082319.1_6656_7459	strA.manually_added_NC_009345_WP_001082319.1_6656_7459	1	0	27	3826	APH_3____Ib+	804	804	100.0	APH_3____Ib+.l15.c30.ctg.1	1385	145.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
strB.manually_added_NC_009345_WP_000480968.1_7459_8295	strB.manually_added_NC_009345_WP_000480968.1_7459_8295	1	0	27	3782	APH_6__Id+	837	837	100.0	APH_6__Id+.l15.c17.ctg.1	1328	148.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
sul2.3000412.AY055428.20268_21084.552	sul2.3000412.AY055428.20268_21084.552	1	0	27	2982	sul2	816	816	100.0	sul2.l15.c4.ctg.1	1461	106.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Sul2 is a sulfonamide resistant dihydropteroate synthase of Gram-negative bacteria, usually found on small plasmids.;sul2
tetA.manually_added_NC_009345_WP_000804063.1_1230_2429	tetA.manually_added_NC_009345_WP_000804063.1_1230_2429	1	0	27	4046	tetA	1200	1200	100.0	tetA.l6.c4.ctg.1	1881	112.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tetR.manually_added_NC_009345_WP_000164043.1_474_1124	tetR.manually_added_NC_009345_WP_000164043.1_474_1124	1	0	27	2482	tetR	651	651	100.0	tetR.l15.c4.ctg.1	1320	98.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	1734	tolC	1488	1488	98.72	tolC.l6.c4.ctg.1	2021	45.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.;tolC
